4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001649989-26-000003
Director bought 34,000 shares at $0.44 ($14,960)
From the SEC's structured data for this filing
Trades in this filing
Haddadin Yezan Munther · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-26 | Purchase : show line 1 in the form | +34,000 | $0.44 | $14,960 | 37,167 | D |
| Open-market purchases · 34,000 sh · avg $0.44 · $14,960 | ||||||
Loading xslF345X06/primary_doc.xml…